Immunogenetics of HTLV-I/II and associated diseases

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Sonoda, Shunro ^a   Fujiyoshi, Toshinobu ^a   Yashiki, Shinji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; HLA haplotypes; HTLV I associated myelopathy tropical spastic paraparesis; Human leukocyte antigen (HLA) alleles; Human T lymphotropic virus types I and II (HTLV I II); Immune responsiveness

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; CONFERENCE PAPER; DISEASE CARRIER; HAPLOTYPE; HLA SYSTEM; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNE RESPONSE; IMMUNOGENETICS; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS INFECTION;

HTLV; HTLV I; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 0029740723     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00020     Document Type: Conference Paper

References (24)

1. Tajima K, Hinuma Y. Epidemiology of HTLV-I/II in Japan and the World. Gann (monogr.) 1992;39:129-49.
2. Wiktor SZ, Blattner WA. Epidemiology of human T-cell leukemia virus type I. In: Gallo RC, Jay G, eds. The human retroviruses. New York: Academic Press, 1991:175-92.
3. Bartholomew C, Charles W, Saxinger C, et al. Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad. Br Med J Clin Res Ed 1985;290:1243-6.
4. Levine PH, Blattner WA, Clark J, et al. Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer 1988;15:7-12.
5. Tajima K. The T- and B-cell malignancy study group. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. Int J Cancer 1990;45:237-43.
6. Kayembe K, Goubau P, Desmyter J, Vlietink R, Carton H. A cluster of HTLV-I-associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiat 1990;53:4-10.
7. Cartier L, Araya F, Castillo JL, et al. Southernmost carriers of HTLV-I/II in the world. Jpn J Cancer Res 1993;84:1-3.
8. Zaninovic V, Sanzon F, Lopez F, et al. Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia. AIDS Res Hum Retroviruses 1994;10:97-101.
9. Fujiyoshi T, Yashiki S, Fujiyama C, et al. Ethnic segregation of HTLV-I and HTLV-II carriers among South American Native Indians, Int J Cancer 1995;63:510-5.
10. Shimotohno K, Takahashi Y, Shimizu N, et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-5.
11. Hall WW, Kubo T, Ijichi S, Takahashi H, Zhu SW. Human T cell leukemia/lymphoma virus type II (HTLV-II): emergence of an important newly recognized pathogen. Semin Virol 1994;5:165-78.
12. Usuku K, Sonoda S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988;23(Suppl):143-50.
13. Sonoda S, Yashiki S, Fujiyoshi T, et al. Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy. Gann (monogr.) 1992; 39:81-93.
14. Hanihara K. Origins and affinities of Japanese viewed from cranial measurements. Acta Anthropogenet 1984;8:149-58.
15. Ishida T, Hinuma Y. The origin of Japanese HTLV-1. Nature 1986;322:564.
16. Yashiki S, Fujiyoshi F, Kuwayama M, Makino M, Takamoto T, Sonoda S. Genetic subpopulations of Japanese: difference in HLA antigens and haplotypes between the southern Kyushu Japanese and the central Japanese population (1996, submitted for publication).
17. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990;348:245-8.
18. + cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991;3:761-7.
19. Parker CE, Daenke S, Nightingale S, Bangham CRM. Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992;188:628-36.
20. Miura S, Ohtani K, Numata N, et al. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 1991;11:1313-25.
21. Katahira Y, Yashiki S, Fujiyoshi T, et al. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res 1995;86:21-7.
22. Nagai M, Yashiki S, Fujiyoshi T, et al. Characterization of T-cell clones established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J Neuroimmunol 1996 (in press).
23. + cytotoxic T-cells from a HAM/TSP patient (1996, submitted for publication).
24. Jacobson S, Zaninovic V, Mora C, et al. Immunological findings in neurological disease associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988;23(Suppl):196-200.